Ponezumab Uses, Dosage, Side Effects and more
Ponezumab is under investigation in clinical trial NCT00607308 (A Phase I, Single Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease).
Trade Name | Ponezumab |
Generic | Ponezumab |
Ponezumab Other Names | PF-04360365, Ponezumab |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |